Link Pharma Chem flips to a ₹7.69 lakh profit for FY26

What's new with Link Pharma Chem Ltd.

• Link Pharma Chem reported a net profit of ₹7.69 lakhs for FY26.
• The company recorded a loss of ₹102.73 lakhs in the previous fiscal year.
• A Q4 loss of ₹40.86 lakhs offset the total annual gains.

Why this matters for Link Pharma Chem Ltd.

Turning a profit is a hurdle for any company, but this nano-cap remains thinly traded with a market value of just ₹13 crore. The reversal to profit is a shift, but the Q4 loss suggests the business model has not found a stable earnings base.

What we're watching

• Whether the company can post consecutive profitable quarters.
• Any shift in the company's trading volumes.
• Whether directors re-appointed in this filing signal a change in direction.

The full read

Link Pharma Chem closed **FY26** with a net profit of **₹7.69 lakhs**, a pivot from the **₹102.73 lakhs** loss reported in **FY25**. For a company with a market cap of only **₹13 crore**, the shift moves the needle on the balance sheet but does little to alter the company's standing as a nano-cap. The annual figure masks volatility within the year, specifically a **₹40.86 lakh** loss in the final quarter. Beyond the bottom line, the filing contains nothing that changes the outlook for the business. The re-appointment of two directors is a routine governance procedure. Investors should view these numbers as a simple accounting reality rather than a sign of operational expansion. The next test is whether the company can sustain its momentum or if it will return to the losses seen in previous cycles.